Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study

BACKGROUND: Metaplastic breast cancer remains poorly characterized given its rarity and heterogeneity. The majority of metaplastic breast cancers demonstrate a phenotype of triple-negative breast cancer; however, differences in clinical outcomes between metaplastic breast cancer and triple-negative...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Surg Oncol
Hauptverfasser: Morgan, Evan, Suresh, Anupama, Ganju, Akaansha, Stover, Daniel G., Wesolowski, Robert, Sardesai, Sagar, Noonan, Anne, Reinbolt, Raquel, VanDeusen, Jeffrey, Williams, Nicole, Cherian, Mathew A., Li, Zaibo, Young, Gregory, Palettas, Marilly, Stephens, Julie, Liu, Joseph, Luff, Amanda, Ramaswamy, Bhuvaneswari, Lustberg, Maryam
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2020
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6961248/
https://ncbi.nlm.nih.gov/pubmed/31937323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-019-1780-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge